Hemp Stocks

827 posts / 0 new
Letzter Beitrag
Selector
Bild des Benutzers Selector
Offline
Zuletzt online: 19.03.2019
Mitglied seit: 06.06.2011
Kommentare: 685
CGC

Dies mal im Voraus:

 

Canopy Growth refiles fiscal 2017 results

2017-11-13 20:13 ET - News Release

 

Mr. Jordan Sinclair reports

CANOPY GROWTH CORPORATION FILES AMENDED AND RESTATED FISCAL YEAR 2017 FINANCIAL RESULTS

Canopy Growth Corp. has filed its amended and restated consolidated financial statements and amended and restated management's discussion and analysis for the year ended March 31, 2017, on SEDAR.

The restatement accounts for:

i) the understated fair value of approximately 11% equity interest and options held by the Company in AusCann Group Holdings Ltd. ("AusCann") by $18.3 million and $5.7 million, respectively, at March 31, 2017 which was previously carried at its cost base of nil being the consideration paid for the minority interest.

The Company has classified its equity interest in AusCann as an available{a ‑}for{a ‑}sale financial asset, an IFRS term. The options represent a derivative financial instrument that is initially recognised at fair value and subsequently remeasured to its fair value at the end of each reporting period. Prior to February 3, 2017 the AusCann shares did not have a quoted market price and the fair value of its equity interest and options in AusCann could not be reliably measured and the equity interest and options were carried at their cost amount of nil.

In the quarter ended March 31, 2017, AusCann completed a capital reorganization and became listed on the Australian Stock Exchange. Following the initial public offering, the Company's shares and options were all placed in escrow until February 3, 2019.

ii) the correction of an immaterial non-cash error in the valuation of biological assets at March 31, 2017, as previously disclosed in the condensed interim consolidated financial statements for the first quarter ended June 30, 2017.

As a result of the restatement, the Company's reported Net Loss was reduced from $16.7 million to a Net Loss of $7.6 million.

Details of the changes are fully described in Note 2 to the Amended and Restated Consolidated Financial Statements for the Year Ended March 31, 2017 as filed on SEDAR on November 13, 2017.

About Canopy Growth Corporation

Canopy Growth is a world-leading diversified cannabis company, offering distinct brands and curated cannabis varieties in dried, oil and capsule forms. Through its wholly‑owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over half a million square feet of GMP-certified indoor and greenhouse production capacity, all to an unparalleled level of quality assurance procedures and testing. Canopy Growth has established partnerships with leading sector names in Canada and abroad, with interests and operations spanning four continents. The Company is proudly dedicated to educating healthcare practitioners, providing consistent access to high quality cannabis products, conducting robust clinical research, and furthering the public's understanding of cannabis. For more information visi twww.canopygrowth.com.

We seek Safe Harbor.

© 2017 Canjex Publishing Ltd. All rights reserved.

Selector
Bild des Benutzers Selector
Offline
Zuletzt online: 19.03.2019
Mitglied seit: 06.06.2011
Kommentare: 685
CGC

Info:  Wink

Canopy Growth comments on Federal Excise Tax Proposal

News provided by

Canopy Growth Corporation

 

13:51 ET

SMITHS FALLS, ON, Nov. 10, 2017 /CNW/ - Canopy Growth Corporation (TSX: WEED) ("Canopy Growth" or the "Company") has been a longtime vocal proponent of a fair and reasonable tax rate that funds important programs needed to successfully transition cannabis out of prohibition. To this point, the Company has spent almost $1-million on its core CSR initiatives over the past three years in key policy areas; research, road safety, and youth education, and commits $1 from the sale of every bottle of cannabis oil to education projects.

 

 

The Company's efforts include funding for important research initiatives such as the Quebec Cannabis Registry, funding a series of PSAs in partnership with MADD Canada and the Canadian Drug Policy Coalition, and committing funding to Parent Action on Drugs and Canadian Students for Sensible Drug Policy to support cannabis-specific education initiatives designed for parents looking for resources to help them talk to their children about responsible choices.  

Today's proposed rate, ten percent on top of existing HST falls within the limit of an acceptable tax framework and is in line with Management's expectation. The proposed rate should allow Canopy Growth and other industry players of various sizes to compete with the black market on price point. Canopy Growth also strongly supports a system that sees the federal and provincial governments collaborate on taxation source and structure. A consistent rate across the country is preferable and would give the Company the confidence it needs to continue creating jobs and investing hundreds of millions of dollars across Canada.

While in some ways the Company understands the policy rationale of including taxation on medical cannabis sales, it is unfortunate that despite Canopy Growth's ongoing advocacy efforts on the subject cannabis will continue to be the only physician-authorized drug in the country subject to sales tax. This is an unfair tax burden on chronically ill Canadians and only further reinforces the need for government, industry and patients to work together to obtain insurance coverage for authorized medical cannabis patients. To that end Canopy Growth is hopeful that revenue from cannabis taxation is earmarked for research to accelerate the Drug Identification Number approval process which is seen as the key to medical insurance coverage for cannabis-based medicines.

Here's to Future Growth.

About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis company, offering distinct brands and curated cannabis varieties in dried, oil and capsule forms. Through its wholly‑owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over half a million square feet of GMP-certified indoor and greenhouse production capacity, all to an unparalleled level of quality assurance procedures and testing. Canopy Growth has established partnerships with leading sector names in Canada and abroad, with interests and operations spanning four continents.  The Company is proudly dedicated to educating healthcare practitioners, providing consistent access to high quality cannabis products, conducting robust clinical research, and furthering the public's understanding of cannabis. For more information visit www.canopygrowth.com.  

Emil
Bild des Benutzers Emil
Offline
Zuletzt online: 21.03.2019
Mitglied seit: 28.09.2007
Kommentare: 3'111
CGC (WEED)

Lorenz hat am 08.11.2017 21:09 geschrieben:

Kurze Frage, ich bin nicht sicher, werden die vorbörslich oder nachbörslich rausgebracht?

Bin da auch seit einiger Zeit dabei und freue mich über die engagierte und gut aufgestellte Unternehmung.

Q-2 von CGC vorbörslich am14.November 2017

Emil

Selector
Bild des Benutzers Selector
Offline
Zuletzt online: 19.03.2019
Mitglied seit: 06.06.2011
Kommentare: 685
CGC-News

@ shanik82

Ja, der Kurs ist auch etrem tief, wäre fast was zum aufsammeln. Zurzeit möchte ich aber nicht dort.

 

Bei CGC war 'Gewinne mitnehmen' schon ok, man sollte dann den Wiedereinstieg nicht verpassen... *blum3**dirol*

 

Canopy Growth, Organa Brands, Green House Seeds Collaborate to bring New Products to Canadian Market and Beyond

SMITHS FALLS, ON, DENVER and AMSTERDAM, Nov. 17, 2017 /CNW/ - Green House Holdings North America Inc. ("Green House"), its affiliate in the Netherlands, GHSC Trading B.V., National Concessions Group Inc. ("Organa Brands") and Canopy Growth Corporation ("Canopy Growth" or "the Company") (TSX: WEED), together three of the most storied and successful global cannabis businesses are pleased to announce the planned creation of a collaborative joint venture (the "JV").

 

 

To establish the JV, Canopy Growth will allocate a portion of ownership in ACMPR-licensed Agripharm Corp. ("Agripharm"), a 20,000 sq. ft. indoor growing facility located in Creemore, Ontario, to its new partners. Canopy Growth will retain 40% ownership of Agripharm, while Green House and Organa Brands will own 40% and 20%, respectively, of Agripharm. In exchange for the issuance of shares, Green House and Organa Brands have granted an exclusive, royalty-free licence in Canada to certain proprietary technology, trademarks, genetics, know-how and other intellectual property to Agripharm, subject to compliance with applicable law.

The JV will create a new Canadian home-base for Green House and Organa Brands where they will work together with Canopy Growth to produce cannabis products for the Canadian market. Pursuant to the JV, the Company has the right to purchase all of the cannabis products produced by Agripharm to be exclusively distributed via Canopy Growth's national channels, subject to limited exceptions. In addition, the Company will sublicense the proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm in order to ensure that Canopy Growth is able to satisfy consumer demand across Canada for the suite of Green House and Organa Brands products.

Although Agripharm is focused on the Canadian market, Canopy Growth, Green House, Organa Brands and their respective affiliates will also explore other federally-legal international opportunities as they arise, including with respect to medical research and development opportunities, product distribution platforms, and brick-and-mortar retail locations. Agripharm will not conduct any business in the United States.

"Our business has separated itself from the competition by focusing on brands and products that resonate with people but also because we've found creative ways to collaborate with like-minded businesses to increase the breadth of our product offering," said Mark Zekulin, President, Canopy Growth. "From world-class breeders like our partners DNA Genetics and now Green House Seeds, to sector innovators like Organa Brands, to cultural icons like Snoop Dogg, we work with the best in order to bring the best possible cannabis forward to our customers."

The JV is expected to close on or about December 1, 2017.  Operationally, Canopy Growth will transfer oversight to its new collaborators who will operate a pristine licensed facility with modular growing rooms designed to produce only the very best cannabis flowers. Green House will oversee day-to-day operations and bring their own expertise into cultivation, while Organa will implement world-class extraction functions as new and novel value-add products become part of the regulatory environment.  Canopy Rivers Corporation, a partly-owned subsidiary of Canopy Growth, has also entered into an agreement to provide the JV with up to $20 million in funding for the expansion of the facility in exchange for ongoing royalty payments and a warrant to acquire up to 4% of the issued and outstanding common shares. 

"For 30 years Green House Brands has been at the forefront of cannabis legalization by advocating for its normalization and expansion into new territories," said Arjan Roskam, the founder of Green House Brands. "We're now operating in four continents (Europe, Africa, South America and North America) and thanks to this new partnership with these two prominent market leaders in the industry, Canopy and Organa Brands, we will create even more opportunities globally to help the world access cannabis in a legal way. This epic move will allow us to maintain our position as a world leader in genetics and cannabis retail, while alerting the cannabis consumer that we will continue striving to make cannabis available worldwide for all medicinal and recreational consumers one day."

Canopy Growth, Green House, and Organa Brands each bring a unique set of skills that are strategically complementary to one another. Canopy Growth has built an online distribution platform that touches every province and territory in Canada as well as 7 international markets; Green House is a genetic leader that has bred some of the world's most sought-after strains; and Organa Brands is an extract product innovator. Together, the JV is positioned to take sought after genetics, insert those genetics into consumer-friendly ingestion formats, and put them on stores shelves across the country, and abroad.

"We are incredibly excited about this new partnership - since the inception of Organa Brands, one of the key tenets of our business has been forming smart partnerships with mutually beneficial results. Working with Canopy and Green House has been a surreal moment as we continue to fully recognize the impact of what this deal means for the industry as a whole" said Organa Brands Co-Founder, Jeremy Heidl. "We couldn't have asked for better partners in Canada and beyond- this new global partnership will prove to be a defining moment for all parties involved."

Cassels Brock & Blackwell LLP acted as legal counsel to Canopy Growth with respect to the JV, Dentons Canada LLP acted as legal counsel to Green House, and Stikeman Elliott LLP acted as legal counsel to Organa Brands.

For more information on this new partnership click here.

Here's to Future Growth.

About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis company, offering distinct brands and curated cannabis varieties in dried, oil and capsule forms. Through its wholly‑owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over half a million square feet of GMP-certified indoor and greenhouse production capacity, all to an unparalleled level of quality assurance procedures and testing. Canopy Growth has established partnerships with leading sector names in Canada and abroad, with interests and operations spanning four continents.  The Company is proudly dedicated to educating healthcare practitioners, providing consistent access to high quality cannabis products, conducting robust clinical research, and furthering the public's understanding of cannabis. For more information visit www.canopygrowth.com

About Green House Holdings North America Inc.
Green House Brands is bringing the most awarded and recognized cannabis brand in the world to the North American market. Established in 1985 in Amsterdam, the Green House Brands portfolio includes five leading marijuana businesses - Strain Hunters, Green House Seed Co., Green House Feeding, Green House Coffee shops & King of Cannabis — as seen on VICE & National Geographic. Green House assets have won the company numerous accolades, including over 40 High Times Cannabis Cups and 200+ awards for top genetics, establishing the company's leadership in the global cannabis industry. Green House was a pioneer in the development of the European cannabis coffee shop market, where its Green House Coffee shops in the Netherlands and Strain Hunters Clubs in Spain remain market leaders.  As Strain Hunters, the company has been featured in documentary series on HBO and VICE, highlighting its globetrotting journeys to find the rarest landrace strains of cannabis. Green House and Strain Hunters media has over 150M views and has one of the most powerful marketing platforms in the industry. Green House enters the rapidly developing legal North American cannabis markets with all of its enterprises. For more information please visit www.greenhousebrands.com

About Organa Brands
Organa Brands revolutionized the cannabis industry with the introduction of supercritical CO₂extracted cannabis oil in 2010 and the introduction of the groundbreaking O.penVAPE device in 2012. Today, the company is home to the world's largest consumer cannabis brands. After developing O.penVAPE, Bakked, and Organa Labs into world-class brands with nationwide distribution, the company acquired The Magic Buzz, and entered into a joint venture to form District Edibles. Organa Brands sells one of its products every 4 seconds around the world, and has delivered over one billion puffs through its flagship O.penVAPE line. A brand incubator and pioneer in the cannabis space, Organa Brands utilizes its 12 production facilities in 11 states and Jamaica to manufacture its extensive catalog of products. Organa Brands sells its cannabis products in over 1,200 retail locations with ancillary hardware sold in thousands of retailers globally– making it the largest cannabis-oil-based consumer products company in the United States. Agripharm– a joint venture between Organa Brands, Canopy Growth Corporation (TSX: WEED), and the world-renowned Greenhouse Seed Company– ushers in a new era of international distribution for the three brand powerhouses. Organa Brands is committed to dominating the global cannabis market through the marriage of science and technology, all for the benefit of the consumer. For more information, please visit www.OrganaBrands.com

Notice Regarding Forward Looking Information
This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Canopy Growth, its subsidiaries or the JV to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Examples of such statements include the issuance of additional common shares, the contribution to be made by Green House and Organa Brands, the purchase of cannabis products by Canopy Growth from Agripharm, the Company's expectations about its positioning and branding in the Canadian market, the Company's collaborative efforts with Green House and Organa Brands internationally, and the expansion of the Agripharm facility. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks associated with: timelines for expansion, including with respect to construction and Health Canada's approval process; availability of additional financing; third-party and regulatory approvals; and such risks contained in the Company's annual information form dated June 28, 2017 and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this press release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

SOURCE Canopy Growth Corporation

For further information: Canopy Growth Contacts: Jordan Sinclair, Director of Communications, Jordan@canopygrowth.com, 613-769-4196; Investor Relations: Tyler Burns, Tyler.burns@canopygrowth.com, 855-558-9333 ex 122; Organa Brands Contacts: Jackson D. Tilley, Director of Public Relations & Community Affairs, 970-518-6452, Jackson@OrganaBrands.com

Related Links

http://canopygrowth.com/

shanik82
Bild des Benutzers shanik82
Offline
Zuletzt online: 24.09.2018
Mitglied seit: 14.01.2015
Kommentare: 35
Revive Therapeutics LTD

...interessante Firma. Extrem tief bewertet (Mkt cap 11Mio). Ich habe mir eine kleine Position gesichert. Was meint Ihr? Top oder Flop?

RVV / 31R

http://www.revivethera.com/

shanik82
Bild des Benutzers shanik82
Offline
Zuletzt online: 24.09.2018
Mitglied seit: 14.01.2015
Kommentare: 35
Lifestyle Delivery Systems NEWS

Lifestyle Delivery Systems Receives Zero Contamination Test Results During Initial Extraction Run and Arranges Five Hundred Thousand Dollar Secured Credit Facility

Vancouver, British Columbia--(Newsfile Corp. - November 21, 2017) - Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF) (FSE: LD6) (WKN: A14XHT) ("LDS" or the "Company") is happy to announce that it has received third-party test results on the finished material extracted from the initial fresh frozen cannabis acquired from Northern California.

The significance of these tests cannot be undermined in light of the expected testing requirements imposed by the state of California starting on January 1st, 2018, which will require that the final product must have at least 99% purity. Based on a report published by Steep Hill (https://www.steephill.com/pdf/uploads/pressrelease/230e778e18d25bf4740957e90b4d7de3.pdf), which states to be the global leader in cannabis testing and analytics, over 84% of the cannabis submitted to Steep Hill's Berkeley lab was contaminated. The Company spent a considerable amount of time identifying the fall harvests which would satisfy high standards LDS set for its raw materials used for the production of CannaStripsTM. Test results showing zero contamination is a significant statement on the LDS Scientific team's acquisition protocols and will clearly enhance the value of downstream products produced from the extracted materials.

The Company estimates the current fall outdoor harvest to represent approximately 80% of the available cannabis production in California until spring 2018. Due to the scarcity of clean raw material, the price to acquire additional raw material in December and January may more than double the current outdoor price. To stockpile sufficient raw fresh frozen material to facilitate production in the fourth quarter of 2017, the Company has arranged a US$500,000 secured credit facility (the "Credit Facility") with an unrelated third party creditor. The Credit Facility will allow the Company to purchase additional raw material without drawing on its development funds and will allow saving more than five hundred thousand dollars in raw material acquisition costs.

Outstanding principal under the Credit Facility accrues interest at a rate of 3% per month, compounded monthly and payable on maturity on May 16, 2018. The Company may prepay the Credit Facility at any time, subject to the payment of $50,000 in minimum interest. The Credit Facility is secured by a general security agreement covering all of the Company's personal property, and first deeds of trust on three parcels of unimproved real property totaling 20.5 acres owned by the Company in the City of Adelanto, San Bernardino County, California.

shanik82
Bild des Benutzers shanik82
Offline
Zuletzt online: 24.09.2018
Mitglied seit: 14.01.2015
Kommentare: 35
...noch mehr LDS NEWS!!!
shanik82
Bild des Benutzers shanik82
Offline
Zuletzt online: 24.09.2018
Mitglied seit: 14.01.2015
Kommentare: 35
LDS in UK & EU!!!
shanik82
Bild des Benutzers shanik82
Offline
Zuletzt online: 24.09.2018
Mitglied seit: 14.01.2015
Kommentare: 35
Aurora and Namaste
Selector
Bild des Benutzers Selector
Offline
Zuletzt online: 19.03.2019
Mitglied seit: 06.06.2011
Kommentare: 685
Ich habe auch noch gesucht

Ich habe auch noch gesucht und keinen News-Alert gefunden bei Aurora. Eigentlich schade. Man kann ja mal etwas hinschauen dort.-

 

Ich habe noch heutige News von CGC

Canopy Growth forms JV for greenhouse-grown cannabis

Dec 18 (Reuters) - Canada’s Canopy Growth Corp said it would form a joint venture with privately owned Canopy Rivers Corp and Quebec-based tomato producer Les Serres Stéphane Bertrand to grow cannabis in a tomato greenhouse.

Canopy Growth will give Bertrand C$2.75 million ($2.14 million) worth of shares and Canopy Rivers will contribute C$15 million in cash.

Bertrand has 700,000 square feet of modern greenhouse, which the companies say would begin producing cannabis by May.

Tomato and pepper are the most common choices to convert to weed as they have similar growth requirements and are also grown in greenhouses.

Canada is on track to legalize recreational marijuana by July and the government’s proposed law also permits adults to grow up to four marijuana plants at home.

However, the Quebec government has said it will not allow residents of the province to grow their own marijuana.

Canopy Growth and Canopy Rivers together will own 66.7 percent of the new company and Bertrand will own the remaining.

$1 = C$1.29 Reporting by Taenaz Shakir in Bengaluru; Editing by Maju Samuel

Our Standards:The Thomson Reuters Trust Principles.

Ausführlicher:

http://www.newswire.ca/news-releases/from-pink-tomatoes-to-purple-buds-canopy-growth-and-les-serres-stephane-bertrand-establish-joint-venture-to-convert-tomato-greenhouse-for-quebec-cannabis-production-664923733.html

 

und auch von heute:

http://www.stockwatch.com/News/Item.aspx?bid=Z-C:WEED-2547387

 

petra129
Bild des Benutzers petra129
Offline
Zuletzt online: 23.03.2019
Mitglied seit: 10.11.2015
Kommentare: 138
Aurora

http://www.stockhouse.com/companies/news?symbol=t.acb

...hier etwas - finde auch keine auf der homepage von Aurora

Lorenz
Bild des Benutzers Lorenz
Offline
Zuletzt online: 20.02.2019
Mitglied seit: 16.04.2010
Kommentare: 1'411
AURORA

Kurze Frage zu AURORA Cannabis (ACB) / TSX

Haben die eigentlich auch einen Newsalert auf der Homepage, ich finde den nicht. Sehe ich schlecht?

https://marijuanastocks.com/aurora-cannabis-inc-acbff-and-cannaroyalty-sign-letter-of-intent-for-international-drug-delivery-technology-agreement/

Selector
Bild des Benutzers Selector
Offline
Zuletzt online: 19.03.2019
Mitglied seit: 06.06.2011
Kommentare: 685
CGC

 

Auch ich bringe noch etwas gute News zum Wochenschluss: SmileDirol

https://www.reuters.com/article/canopy-growth-cannabis/cannabis-maker-canopy-growth-expands-to-newfoundland-and-labrador-idUSL3N1O84LA

 

News provided byCanopy Growth Corporation

08:12 ET

 

Share this article

 

ST. JOHN'S & SMITHS FALLS, ON, Dec. 8, 2017 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") along with representatives from the Province of Newfoundland and Labrador today are pleased to announce that the Company has entered into a supply and production agreement, the largest provincial cannabis supply agreement announced to date, securing a regulated supply of cannabis for Newfoundlanders and Labradorians heading into the legal adult access market.

-->

Tweed, DNA Genetics, and Leafs By Snoop are some of the many brands sold under Canopy Growth's portfolio (CNW Group/Canopy Growth Corporation)

Tweed, DNA Genetics, and Leafs By Snoop are some of the many brands sold under Canopy Growth's portfolio (CNW Group/Canopy Growth Corporation)

-->

Canopy Growth will supply 8,000 kg of high quality cannabis products annually for the first two years of the deal. Under the terms of the agreement, Canopy Growth will establish a new production facility in Newfoundland and Labrador capable of producing 12,000 kg per year, bringing 145 jobs in an emerging sector and major capital investment to the region. Site locations are being evaluated to house what could be the first licensed production facility in the province.

"This agreement today with an internationally recognized producer not only guarantees a safe supply of cannabis for Newfoundland and Labrador before the federally imposed July 2018 implementation date, but also results in the creation of 145 new jobs in our province," said the Honourable Christopher Mitchelmore, Minister of Tourism, Culture, Industry and Innovation, Newfoundland and Labrador. "We will also use this as a framework for other agreements related to cannabis supply and production. Our vision is for an industry which leads to production, job creation, supply chain development and research and development in this province."

"Canopy's operations will soon stretch from Coast to Coast, with locations now planned in seven provinces including Newfoundland and Labrador," said Bruce Linton, Chairman & CEO, Canopy Growth. "Wherever we operate we look for ways to integrate ourselves into the local community to make sure we are giving back to the communities we call home."

Canopy's wholly-owned subsidiary, Tweed Inc. ("Tweed") will also be eligible to apply to operate four new retail locations in the province. This would be a major milestone for Tweed, a leading brand in today's cannabis industry. These four licences would represent the first announced privately owned and operated legal cannabis retail locations in the country. Site scouting is underway, with two locations possible on the Avalon Peninsula, one west of the Avalon Peninsula, and another at the future production site. Canopy Growth and Tweed are also seeking retail locations at their production facilities in other provinces, a common practice for breweries and wineries across Canada.

Mr. Linton continued, "The Newfoundland and Labrador retail framework will allow us to take our existing e-commerce business and well-recognized house of brands including Tweed, DNA Genetics, Leafs By Snoop, and our CraftGrow program, and present that pride and dedication in a "brick and mortar" retail environment. I want to congratulate the Government of Newfoundland and Labrador for choosing a retail model that encourages local growth and a made-at-home experience, while balancing private and public involvement."

Tweed has a long track record of responsible cannabis sales as a medical producer and has partnered with organizations like MADD Canada and Parent Action on Drugs to ensure Canada exits prohibition in a responsible way. The Company looks forward to establishing welcoming and warm retail spaces that prioritize top-notch customer service and product education, supported by Canada's largest cannabis production platform and a wide number of CraftGrow partnerships to bring cannabis of all forms and sizes to the people of Newfoundland & Labrador......

Quelle:

http://www.newswire.ca/news-releases/newfoundland--labrador-and-canopy-growth-enter-comprehensive-supply-development-and-retail-agreement-662773873.html

 

Emil
Bild des Benutzers Emil
Offline
Zuletzt online: 21.03.2019
Mitglied seit: 28.09.2007
Kommentare: 3'111
Ich habe hie mega coole News

Ich habe hie mega coole News gesehen heute, gut wieder dabei zu sein.  SmileDirol

2017-12-05 07:21 ET - News Release

 

Mr. Bruce Linton reports

SPECTRUM CANNABIS DENMARK ANNOUNCES FORTY THOUSAND SQUARE METRE MEDICAL CANNABIS FACILITY IN ODENSE

Spectrum Cannabis Denmark ApS, a joint venture between Canopy Growth Corp. and Danish Cannabis ApS, a leading European hemp producer, plans to establish a 40,000-square-metre production facility in Odense, Denmark. The immediate conversion of 30,000 m2 of existing greenhouse infrastructure could be completed as soon as early 2018, subject to regulatory approvals and licensing, and has the full support of Odense Mayor Peter Rahbak Juel.

"We are pleased that our efforts to create a stable, skilled and safe environment continues to attract global businesses to Odense, which will now share in the prosperity of the largest and most reputable medical cannabis company in the world," said Mayor Juel.

Denmark is an ideal country for greenhouse cannabis production because of the abundant availability of experienced greenhouse producers and labourers. Odense was specifically chosen because of the support of the greenhouse industry that exists in the area.

The Odense facility is expected to employ over 125 staff, including its former orchid growers who will all be offered employment with the Company. Based on current usage rates in Canadian patient groups, production capacity from the state-of-the art greenhouse could serve the needs of approximately 60,000 patients, with a retail production value of over 500 M DKK.

While the Company proceeds through the Lagemiddelstyrelsen licensing process for production, it expects to import Spectrum Cannabis products from Canada, which are currently sold to medical patients in Canada and Germany.

The Spectrum Cannabis products are based on the simple doctor and patient friendly Spectrum system, which classifies products from high THC to balanced THC and CBD products to high CBD-only products. Throughout 2018, the Company intends to introduce its range of products in dried form for inhalation, as well as cannabis oils and Softgel capsules, an offering currently only available through Canopy Growth's subsidiaries, Spectrum Cannabis and Tweed.

"The Danish market is a stable, attractive market for a number of strategic reasons," said Bruce Linton, Chairman and CEO of Canopy Growth. "In Denmark, we see a strong pharmaceutical industry with an equally strong research tradition as well as a skilled labour pool and attractive energy rates. Based on these foundational aspects and with the expertise of our partners at Danish Cannabis, I am confident we will build upon our global success here in Denmark."

The confidence and trust in the medical control system exercised by Lagemiddelstyrelsen and the evolving cannabis laws in Denmark have created a market opportunity that will create jobs for the community of Odense while also improving the health and quality of lives of Danish people suffering from chronic illnesses by providing a safe and consistent supply of high quality medical cannabis products.

Subject to regulatory approvals, a variety of Spectrum Cannabis products will be available throughout 2018, including over ten dried cannabis strains, and ingestible cannabis oils available in liquid and Softgel capsule formats.

Here's to Future Danish Growth.

Emil

Selector
Bild des Benutzers Selector
Offline
Zuletzt online: 19.03.2019
Mitglied seit: 06.06.2011
Kommentare: 685
Ja durchaus. Schade, sind es

Ja durchaus. Schade, sind es OTC-Titel, sonst würde es mich eher interessieren. Solche die in USA auch kotiert sind, interessieren mich für diese Branche allerdings nicht. Andere sind eventuell interessiert.-

 

Zu CGC, hier noch eine Meldung von Bedeutung, dat. von gestern:

2017-11-28 07:15 ET - News Release

See News Release (C-WEED) Canopy Growth Corp

Mr. Mark Zekulin of Canopy reports

CANOPY GROWTH ADDS MANITOBA-BASED LICENSED PRODUCER DELTA 9 TO THE CRAFTGROW FAMILY

Canopy Growth Corp. has entered into a distribution agreement with Winnipeg-based Delta 9 Cannabis Inc. Delta 9 will offer its well-established cannabis products through Canopy Growth's curated CraftGrow line via Tweed Main Street's on-line store, alongside other high-quality cannabis varieties grown by a diverse set of producers.

Delta 9 was founded in 2012, and quickly became the fourth fully licensed producer and distributor of medical cannabis in Canada. Currently operating an 80,000-square-foot production facility in east Winnipeg, Delta 9 is focused on growing small-batch, hand-trimmed medical cannabis strains in its innovative, self-designed grow pod systems. As Manitoba has recently unveiled its proposed cannabis distribution model, which includes private sales, Delta 9 will work with Canopy Growth to continue to serve the local market with consistent high-quality standardized cannabis products, while gaining access to consumers across the country through Canopy Growth's on-line marketplace.

"We recognize the varied needs of our patients and through the CraftGrow program we aim to bring them the highest-quality products from a variety of producers that each bring a unique offering forward," said Mark Zekulin, president of Canopy Growth. "This is the ninth participant in the CraftGrow program, and we are particularly excited to see one of the earliest established producers in our sector come on board. We want to promote the value of our platform approach and welcoming Delta 9's products to our shop speaks volumes to the CraftGrow program's potential."

Canopy Growth's CraftGrow line aims to build an ecosystem of high-quality cannabis options for patients across the country. As the newest member of the CraftGrow family, Delta 9 will gain direct access to Canopy Growth's extensive operational, distribution, marketing and sales infrastructure through the Tweed Main Street on-line marketplace where a gram is shipped on average every four seconds. Its sector-leading fulfilment centre then ships these orders to customers all across the country.

"Our company is excited to further our growing partnership with Canopy Growth," said Delta 9 chief executive officer John Arbuthnot. "We are already working closely on a project to jointly serve the growing market in Manitoba; this project brings Delta 9's craft grown cannabis products to a wider national audience through Canopy's well-established CraftGrow network."

Canopy Growth is committed to growing a thriving cannabis marketplace that offers diversity of producers and products to valuable customers. The CraftGrow program is an integral part of an effective cannabis ecosystem, and the addition of Delta 9 strengthens the program and supports continuing success.

About Canopy Growth Corp.

Canopy Growth is a world-leading diversified cannabis company, offering distinct brands and curated cannabis varieties in dried, oil and capsule forms. Through its wholly owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over 700,000 square feet of licensed production, over 500,000 square feet of which are GMP-certified. Looking forward to 2018, Canopy Growth and its affiliates are developing a production platform that will represent 3.2 million square feet of indoor and greenhouse production capacity, all operated with world-leading production, quality assurance procedures, value-add postprocessing, research and testing. Canopy Growth has established partnerships with leading sector names in Canada and abroad, with interests and operations spanning seven countries and four continents.

About Delta 9 Cannabis Inc.

Delta 9's wholly owned subsidiary, Delta 9 Bio-Tech, is a licensed producer of medical marijuana pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) and operates an 80,000-square-foot, expandable, state-of-the-art production facility in Winnipeg, Man., Canada.

We seek Safe Harbor.

© 2017 Canjex Publishing Ltd. All rights reserved.

shanik82
Bild des Benutzers shanik82
Offline
Zuletzt online: 24.09.2018
Mitglied seit: 14.01.2015
Kommentare: 35
Momentan viel Bewegung in Kanada!
  • Lifestyle Delivery Systems +60% in 5 Tage
  • Revive Therapeutics +80% in 3 Monate
  • Namaste Technologies +111% in 1 Monat

 

Lorenz
Bild des Benutzers Lorenz
Offline
Zuletzt online: 20.02.2019
Mitglied seit: 16.04.2010
Kommentare: 1'411
Aurora (ACB)

Ich verfolge hier etwas den Kurs. Das sind auch Kanadier. Wie findet ihr diese Info von heute:

Aurora Cannabis to raise $200-million in bought deal

2018-01-05 08:03 ET - News Release

 

Mr. Terry Booth reports

AURORA CANNABIS ANNOUNCES $200 MILLION BOUGHT DEAL FINANCING

Aurora Cannabis Inc. has entered into an agreement with a syndicate of underwriters, led by Canaccord Genuity Corp., pursuant to which Canaccord Genuity has agreed to purchase, on a bought deal basis, 200,000 convertible debentures, at a price of $1,000 per initial convertible debenture, for gross proceeds of $200-million.

Aurora has also granted Canaccord Genuity an option (the "Option"), exercisable up to 30 days after closing of the Offering, to purchase up to an additional 30,000 convertible debentures (the "Additional Convertible Debentures" and, together with the Initial Convertible Debentures, the "Convertible Debentures") for additional gross proceeds of $30 million. If the Option is exercised in full, the aggregate gross proceeds of the Offering will be $230 million.

The Convertible Debentures will have a maturity date of two years from the closing date of the Offering (the "Maturity Date") and will bear interest from the date of closing at 5.0% per annum, payable semi-annually on June 30 and December 31 of each year. The Convertible Debentures will be convertible, at the option of the holder, into common shares of the Company ("Common Shares") at any time prior to the close of business on the last business day immediately preceeding the Maturity Date at a conversion price of $13.05 per Common Share (the "Conversion Price"). The Company may force the conversion of the principal amount of the then outstanding Convertible Debentures at the Conversion Price on not less than 30 days' notice should the daily volume weighted average trading price of the Common Shares be greater than $17.00 for any 10 consecutive trading days.

"This is the largest bought deal financing to date in the Canadian cannabis sector, and represents a tremendous vote of confidence in Aurora's business strategy, consistent execution and accretive deployment of resources," said Terry Booth, CEO. "Our unparalleled balance sheet, capital markets strength, and consistently decreasing cost of capital position us ideally to execute on multiple attractive opportunities in Canada and around the world."

Upon a change of control of the Company, holders of the Convertible Debentures will have the right to require the Company to repurchase their Convertible Debentures, in whole or in part, on the date that is 30 days following the giving of notice of the change of control, at a price equal to 104% of the principal amount of the Convertible Debentures then outstanding plus accrued and unpaid interest thereon (the "Offer Price"). If 90% or more of the principal amount of the Convertible Debentures outstanding on the date of the notice of the change of control have been tendered for redemption, the Company will have the right to redeem all of the remaining Convertible Debentures at the Offer Price.

The Offering is in the form of a bought deal public offering (i) in each of the provinces and territories of Canada (other than Quebec), (ii) in the United States only to Qualified Institutional Buyers (within the meaning of Rule 144A), and in each case in compliance with the securities laws of the applicable states of the United States, to investors that the underwriters have reasonable grounds to believe and do believe are Qualified Institutional Buyers, and (iii) outside Canada and the United States on a basis which does not require the qualification or registration of any of the Convertible Debentures or Common Shares.

Closing of the Offering is expected to occur on or about January 31, 2018 (the "Closing Date"). The Offering is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and stock exchange approvals, including the approval of Toronto Stock Exchange.

About Aurora

Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations ("ACMPR"). The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, known as "Aurora Mountain", a second 40,000 square foot high-technology production facility known as "Aurora Vie" in Pointe-Claire, Quebec on Montreal's West Island, and is currently constructing an 800,000 square foot production facility, known as "Aurora Sky", at the Edmonton International Airport, as well as is completing a fourth facility in Lachute, Quebec through its wholly owned subsidiary Aurora Larssen Projects Ltd.

In addition, the Company holds approximately 17.23% of the issued shares in leading extraction technology company Radient Technologies Inc., based in Edmonton, and is in the process of completing an investment in Edmonton-based Hempco Food and Fiber for an ownership stake of up to 50.1%. Furthermore, Aurora is the cornerstone investor with a 22.9% stake in Cann Group Limited, the first Australian company licensed to conduct research on and cultivate medical cannabis. Aurora also owns Pedanios, a leading wholesale importer, exporter, and distributor of medical cannabis in the European Union, based in Germany. The Company offers further differentiation through its acquisition of BC Northern Lights Ltd. and Urban Cultivator Inc., industry leaders, respectively, in the production and sale of proprietary systems for the safe, efficient and high-yield indoor cultivation of cannabis, and in state-of-the-art indoor gardening appliances for the cultivation of organic microgreens, vegetables and herbs in home and professional kitchens. Aurora's common shares trade on the TSX under the symbol "ACB".

We seek Safe Harbor.

© 2018 Canjex Publishing Ltd. All rights reserved.

zuchtbulle78
Bild des Benutzers zuchtbulle78
Offline
Zuletzt online: 02.11.2018
Mitglied seit: 03.07.2015
Kommentare: 45
Hanf-Aktien sell-off

das wird der Grund sein:

Hemp, Inc. (OTC PINK: HEMP) executives respond today to the U.S. Attorney General Jeff Sessions’ decision to rescind the Cole memo that ignited a marijuana stock sell-off

whussa-solutions
Bild des Benutzers whussa-solutions
Offline
Zuletzt online: 17.01.2018
Mitglied seit: 14.01.2014
Kommentare: 26
aktuell Gewinnmitnahmen?

Weiss jemand was los ist im Hempmarkt? Sprechen wir da noch von normalen Gewinnmitnahmen oder habe ich was verpasst?

Selector
Bild des Benutzers Selector
Offline
Zuletzt online: 19.03.2019
Mitglied seit: 06.06.2011
Kommentare: 685
CGC (WEED)

Wunderbar, gewaltig, seit dem 23. Dezember 2017 hat sich der Kurs verdoppelt und steht nun bei ca. C$ 42.-/43.-.

Ich stehe nun mal an die Seitenlinie. Wiedereinstieg geplant. Man wird sehen.

Selector
Bild des Benutzers Selector
Offline
Zuletzt online: 19.03.2019
Mitglied seit: 06.06.2011
Kommentare: 685
CGC (WEED)

(@Lorenz, betr. Aurora, Kanada. Danke für den Hinweis von heute 16:21h, ich sehe dann da eher Kurs-Stagnation).

 

Info:

News provided byCanopy Growth Corporation

07:11 ET

SMITHS FALLS, ON, Jan. 5, 2018 /CNW/ - In response to news out of the United States Department of Justice yesterday morning regarding federal cannabis laws in the United States and further to press releases issued Oct 17, 2017 and Aug. 4, 2017, Canopy Growth Corporation (TSX: WEED) ("Canopy Growth" or the "Company") wishes to reiterate its commitment to only conducting business in jurisdictions where that conduct is federally legal and otherwise in compliance with all applicable laws.

 

 

Canopy Growth does not and will not conduct business in any jurisdiction unless it is federally permissible. Conducting activities which are federally illegal, or investing in companies which do, exposes the Company to increased risk of prosecution. Such activities would compromise Canopy Growth's ability to operate freely, and could jeopardize the Company's listing eligibility on major securities exchanges now and in the future, and limit access to capital from reputable US-based funds and world-class partners.

"We want to make our position as clear as possible: While Canopy does not support continued cannabis prohibition, it is Management's view that confusion surrounding federal cannabis laws in the United States presents advantages for Canopy Growth, not risks. We are confident in our position because we have exclusively focused on ethical, responsible and legal cannabis opportunities across the globe and not in the United States," said Bruce Linton, Chairman & CEO, Canopy Growth. "We want to assure our shareholders that they are not being exposed to undue risk."

Here's to Future Growth.

About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms.  From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.

Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few.  Canopy Growth operates seven cannabis production sites with over 665,000 square feet of production capacity, including over 500,000 square feet of GMP-certified production space. The Company has operations in seven countries across four continents. The Company is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and through its partly owned subsidiary, Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development. Through partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment to new market entrants and building a portfolio of stable investments in the sector. From our historic public listing to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. For more information visit www.canopygrowth.com 

Notice Regarding Forward Looking Statements
This news release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Canopy Growth Corporation, its subsidiaries, or its affiliates to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Examples of such statements include future operational and production capacity, the impact of enhanced infrastructure and production capabilities, and forecasted available product selection.  The forward-looking statements included in this news release are made as of the date of this news release and Canopy Growth Corporation does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Neither the TSX Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Canopy Growth Corporation

For further information: Jordan Sinclair, Director of Communications, Jordan@tweed.com, 613-769-4196; Investor Relations: Tyler Burns, Tyler.burns@canopygrowth.com, 855-558-9333 ex 122; Director: Bruce Linton, tmx@tweed.com

Related Links

http://canopygrowth.com/

Cherokee
Bild des Benutzers Cherokee
Offline
Zuletzt online: 12.12.2018
Mitglied seit: 07.08.2017
Kommentare: 20
HMMJ

Ich bin überzeugt der Hanfmarkt hat eine grosse Zukunft. In Kanda könnte die Legalisierung bereits Mitte 2018 kommen. In Uruguay ist es bereits legal, ebenso in Ecuador (Eigengebrauch), in teilen der USA und in den Niederlanden wirds toleriert. Ich habe mir deshalb eine kleine Position des ETF HMMJ aufgebaut. Die Zeit wird zeigen wie es weiter geht.

Selector
Bild des Benutzers Selector
Offline
Zuletzt online: 19.03.2019
Mitglied seit: 06.06.2011
Kommentare: 685
Machst du halt mal Pause bis

Machst du halt mal Pause bis zum 7. Februar. Am 22. Februar ist dann aber Q3 geplant.  Smile DirolWink

Lorenz
Bild des Benutzers Lorenz
Offline
Zuletzt online: 20.02.2019
Mitglied seit: 16.04.2010
Kommentare: 1'411
Vermutlich kann man es

Vermutlich kann man es vorläufig bei CGC auch mal vergessen - oder?

Info: Overnight

Canopy Growth Corporation Announces $175 Million Bought Deal Financing

SMITHS FALLS, ONTARIO--(Marketwired - Jan. 17, 2018) -

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.

Canopy Growth Corporation (TSX:WEED) ("Canopy Growth" or the "Corporation") announced today that it has entered into an agreement with a syndicate of underwriters co-led by GMP Securities L.P. ("GMP") and BMO Capital Markets as joint bookrunners ("BMO" and together with GMP, the "Co-Lead Underwriters" and collectively with the syndicate, the "Underwriters"), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis pursuant to the filing of a short form prospectus, 5,060,000 common shares (the "Common Shares") of the Corporation at a price of $34.60 per Common Share (the "Offering Price") for aggregate gross proceeds to Canopy Growth of $175,076,000 (the "Offering"). 

The Corporation has agreed to grant the Underwriters an over-allotment option to purchase up to an additional 759,000 Common Shares at the Offering Price, exercisable in whole or in part, at any time on or prior to the date that is 30 days following the closing of the Offering. 

The Common Shares will be offered by way of a short form prospectus to be filed in all provinces of Canada (except Quebec). The Company intends to use the net proceeds from the Offering for capital expenditures for capacity expansion, working capital, and general corporate requirements. The Offering is expected to close on February 7, 2018 and is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and stock exchange approvals, including the approval of the Toronto Stock Exchange and the applicable securities regulatory authorities.

The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from the registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful.

Here's to Future Growth.

About Canopy Growth Corporation

Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.

Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates seven cannabis production sites with over 665,000 square feet of production capacity, including over 500,000 square feet of GMP-certified production space. The Company has operations in seven countries across four continents. The Company is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and through its partly owned subsidiary, Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development. Through partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment to new market entrants and building a portfolio of stable investments in the sector. From our historic public listing to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. For more information visit www.canopygrowth.com

 

 

Selector
Bild des Benutzers Selector
Offline
Zuletzt online: 19.03.2019
Mitglied seit: 06.06.2011
Kommentare: 685
CGC

Hier war noch was, das ich euch sagen wollte, aber ich kam nicht dazu.

Die Info ist vom 10. Januar und ich finde sie ganz interessant (der Kurs ist es auch, gerade jetzt):

2018-01-10 09:54 ET

CANOPY RIVERS CLOSES OVERSUBSCRIBED $26 MILLION FINANCING VIA PRIVATE PLACEMENT

Canopy Growth Corp.'s partly owned subsidiary, Canopy Rivers Corp. has closed a non-brokered private placement offering of 23,636,363 Class B common shares at a price of $1.10 per share. Pursuant to the offering, Canopy Rivers raised aggregate gross proceeds of approximately $26-million. Canopy Growth subscribed for 4,673,938 shares for $5,141,331.80.

"Canopy Rivers has efficiently allocated the initial capital and quickly established an attractive portfolio of diversified investments including licensed producers, late-stage applicants, ancillary-product developers and industry-leading brands," says Bruce Linton, chief executive officer of Canopy Growth and chairman of Canopy Rivers.

Founded in April, 2017, Canopy Rivers was formed to complete streaming deals to flow product through Canopy Growth's platform and diversify supply channels to satisfy the needs of Canada's largest group of cannabis customers. As the Canopy Rivers leadership team evaluated the landscape and identified additional deal potential, a more robust business model matured to complement streaming activities. Today, Canopy Rivers has a portfolio of diversified investments and represents a balanced mix of equity, debt, royalty and profit-sharing investment structures.

"Our team has curated a tier one group of complementary but unique investee companies in a short period of time," said Sean McNulty, co-founder of Canopy Rivers. "We have pioneered a series of offtake and strategic support programs and efficiently leveraged the resources of Canopy Growth's cannabis production and distribution platform in a way that creates long-term value for our investors."

Canopy Growth controls the majority voting rights in Canopy Rivers and holds an approximate 30-per-cent-equity stake on a non-diluted basis. The balance of Canopy Rivers shares is held by strategic partners and private investors, including members of both Canopy Growth and Canopy Rivers who participated in this financing round.

"The cannabis investment landscape continues to become more crowded and difficult for investors to track, evaluate and differentiate. Canopy Rivers offers its investors financial exposure to a funnel of domestic and international opportunities, with both private and public companies, in risk-mitigated structures that are typically not prevalent in conventional financial markets. This funnel is filtered, evaluated and scrutinized by a team of financial and legal professionals, and ultimately vetted by the largest and most sophisticated cannabis company in the world. We are in the infancy of this globally emerging industry and our pipeline of opportunities has never been more robust," says Peter Hatziioannou, co-founder of Canopy Rivers.

Proceeds of the private placement will be used to provide growth capital in various forms, including, but not limited to, the purchase of a right to cannabis production, royalty transactions and other strategic investments in or providing financing for companies either licensed to produce cannabis or companies that have applied, or are in the process of applying, for a licence to produce cannabis as well as for working capital and general corporate purposes. Rivers is committed to exclusively investing and supporting firms operating in federally legal jurisdictions.

 

petra129
Bild des Benutzers petra129
Offline
Zuletzt online: 23.03.2019
Mitglied seit: 10.11.2015
Kommentare: 138
CHART GUYS UPDATE 1/9/2018
shanik82
Bild des Benutzers shanik82
Offline
Zuletzt online: 24.09.2018
Mitglied seit: 14.01.2015
Kommentare: 35
Full Production Begins @ LDS
Emil
Bild des Benutzers Emil
Offline
Zuletzt online: 21.03.2019
Mitglied seit: 28.09.2007
Kommentare: 3'111
CGC / Video

Wie gewünscht.  GoodWinkSmile .  Super, wir bekommen in den nächsten Wochen einige Short-Videos, damit wir auch dabei sind und mitverfolgen können.

https://www.youtube.com/watch?v=c9qhIX7Kk_c  

Best regards,  

Tyler Burns

Investor Relations

Canopy Growth Corporation

C: 613-697-0367

T: 613-706-2185 ext. 122

www.canopygrowth.com

 

Emil

Selector
Bild des Benutzers Selector
Offline
Zuletzt online: 19.03.2019
Mitglied seit: 06.06.2011
Kommentare: 685
CGC / Liefervereinbarung

Heute wieder gute News Smile  Dirol  (war kurz weg, danke für die Info @ Emil)

Presse:

http://www.stockwatch.com/News/Item.aspx?bid=Z-C:WEED-2592370

Canopy Growth completes three year supply agreement with the Société des alcools du Québec

Canada NewsWire

SMITHS FALLS, ON, April 11, 2018 /CNW/ - Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) today announced that it has completed a three year supply agreement with the Société des alcools du Québec ("SAQ") for 12,000 kgs of high-quality cannabis products.

Securing this long term agreement marks another important step in preparing for a legal recreational market in the province of Quebec, and builds upon the letter of intent signed in early February of this year.

"This agreement is an exciting next step in delivering a wide range of our safe, high-quality products to consumers across the province," said Mark Zekulin, President, Canopy Growth. "Quebec is home for Canopy Growth and we're proud to be advancing this long term partnership to develop the Québec market."

Canopy Growth has well-established presence in the province of Québec through its wholly- owned subsidiary Vert Cannabis in Saint Lucien and Vert Mirabel, a company recently formed with Canopy Rivers and Les Serres Stéphane Bertrand Inc., a large-scale greenhouse operator in Mirabel. The 700,000 sq. ft. greenhouse at Vert Mirabel is currently being retrofitted and optimized for cannabis production.

The supply agreement is conditional upon the federal and provincial governments adopting the necessary regulatory framework. 

This agreement is a milestone of significance for the Canadian cannabis industry as a whole and accordingly, congratulations are in order for other licensed producers who have completed their first agreements with the SAQ, marking a truly historic day for the sector.

Quelle:

https://web.tmxmoney.com/article.php?newsid=5914099085737154&qm_symbol=WEED

 

 

Emil
Bild des Benutzers Emil
Offline
Zuletzt online: 21.03.2019
Mitglied seit: 28.09.2007
Kommentare: 3'111
Info

Ich habe erst jetzt gesehen, dass wir noch News bekommen haben, supergute und es freut, dass hier soviel entsteht und wächst!

 

Canopy to develop pot-based medicines with Beckley

2018-04-09 06:46 ET - News Release

http://www.stockwatch.com/News/Item.aspx?bid=Z-C:WEED-2591379

Mr. Bruce Linton reports

GLOBAL CANNABIS RESEARCH LEADERS BECKLEY FOUNDATION AND CANOPY HEALTH INNOVATIONS PARTNER TO FORM BECKLEY CANOPY THERAPEUTICS

Canopy Growth Corp. has launched Beckley Canopy Therapeutics, a partnership between its affiliate and biopharmaceutical research arm Canopy Health Innovations and drug research pioneer Lady Amanda Feilding and the Beckley Foundation.

Beckley Canopy has been formed to research and develop clinically validated cannabis-based medicines, with a strong focus on intellectual property protection. The partnership will combine Amanda Feilding's plus-20-year record of groundbreaking research and network of world-renowned scientific collaborators with Canopy Health's leadership in the commercial cannabis and pharmaceutical industries, bringing together European and North American based research leaders in cannabis.

"We are delighted to have formed this partnership with Beckley. They have been leading the way in drug policy reform and cannabis research for more than two decades and we feel that our skill sets complement each other perfectly," said Marc Wayne, chief executive officer of Canopy Health. "This is a unique opportunity to expand our operations, conduct world-class research, and meet the needs of doctors and patients around the world."

As part of its business model, Beckley Canopy will engage in a number of research areas to establish an intellectual property portfolio and develop innovative cannabis-based pharmaceutical and natural health products. In doing so, it plans to work with cannabis genetics and other products provided by its strategic partner, Canopy Growth, the largest cannabis company in the world.

"For over half a century, I have been committed to scientifically investigating the potential benefits of certain psychoactive compounds for the treatment of illnesses and for the enhancement of well-being," said Amanda Feilding, founder and executive director of the Beckley Foundation. "Twenty years ago, I set up the Beckley Foundation in order to bridge the divide between science and drug policy. We have come a very long way since then and have now begun an exciting new chapter where science can be used to provide safe and effective cannabis medicines for people in need all over the world. I am thrilled to have Canopy Health as our partners in this new venture. I have great faith not only in their capabilities but also in their commitment to maintaining the Beckley Foundation's ethical standards in everything we do together."

Staying true to both partner organizations' commitment to corporate social responsibility, Beckley Canopy will donate a share of all profits from future commercialized products to support the not-for-profit scientific research and policy work of the Beckley Foundation.

Beckley Canopy's first intellectual-property-generating research in humans is already under way: a brain imaging trial looking at the effects of a proprietary cannabinoid formulation in the treatment of a major indication. Additional research and product development programs are scheduled to start in 2018. As IP positions are secured, further information will be provided.

Here's to future (scientific research) growth.

About Canopy Growth Corp.

Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.

Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates seven cannabis production sites with over one million square feet of production capacity, including over 500,000 square feet of GMP-certified production space.

We seek Safe Harbor.

© 2018 Canjex Publishing Ltd. All rights reserved.

 

Emil

Seiten